This statistic shows the market share of the hyperimmunes market in the U.S. in 2016. Grifols had the largest hyperimmunes market share with some 51 percent while Kedrion had the second largest market share with some 18 percent.
Market share of the U.S. hyperimmunes market in 2016, by company
Characteristic
Market share
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Grifols. (June 7, 2017). Market share of the U.S. hyperimmunes market in 2016, by company [Graph]. In Statista. Retrieved September 01, 2024, from https://www.statista.com/statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols. "Market share of the U.S. hyperimmunes market in 2016, by company." Chart. June 7, 2017. Statista. Accessed September 01, 2024. https://www.statista.com/statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols. (2017). Market share of the U.S. hyperimmunes market in 2016, by company. Statista. Statista Inc.. Accessed: September 01, 2024. https://www.statista.com/statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols. "Market Share of The U.S. Hyperimmunes Market in 2016, by Company." Statista, Statista Inc., 7 Jun 2017, https://www.statista.com/statistics/758043/hyperimmunes-market-share-in-us-by-company/
Grifols, Market share of the U.S. hyperimmunes market in 2016, by company Statista, https://www.statista.com/statistics/758043/hyperimmunes-market-share-in-us-by-company/ (last visited September 01, 2024)
Market share of the U.S. hyperimmunes market in 2016, by company [Graph], Grifols, June 7, 2017. [Online]. Available: https://www.statista.com/statistics/758043/hyperimmunes-market-share-in-us-by-company/